Donald Berry

发表

A nonparametric Bayesian basket trial design

Peter Müller, Yanxun Xu, Apostolia M Tsimberidou, 2016, Biometrical journal. Biometrische Zeitschrift.

Statistical Science Underlying Trial Design

Donald Berry, 2019 .

Personalized Medicine for Patients with Advanced Cancer in the Phase I Program at MD Anderson: Validation and Landmark Analyses

Razelle Kurzrock, Sijin Wen, Donald Berry, 2014, Clinical Cancer Research.

Bayesian Continual Reassessment Method for Dose-Finding Trials Infusing T Cells with Limited Sample Size

Yuan Ji, Ping Liu, Donald Berry, 2012, Journal of biopharmaceutical statistics.

Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.

Oguzhan Alagoz, Rebecca A Hubbard, Karla Kerlikowske, 2014, Journal of the National Cancer Institute.

The Design of Phase II Clinical Trials Testing Cancer Therapeutics: Consensus Recommendations from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee

Susan Groshen, Larry Rubinstein, Lesley Seymour, 2010, Clinical Cancer Research.

Validity of Models for Predicting BRCA1 and BRCA2 Mutations

Leif E. Peterson, Giovanni Parmigiani, Li Hsu, 2007, Annals of Internal Medicine.

Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840.

Lyndsay Harris, Donald Berry, Larry Norton, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies

Oguzhan Alagoz, Karla Kerlikowske, Xuelin Huang, 2016, Annals of Internal Medicine.

Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative

Razelle Kurzrock, Sijin Wen, Rajyalakshmi Luthra, 2012, Clinical Cancer Research.

Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer

Roman Rouzier, Lajos Pusztai, Donald Berry, 2006, Cancer.

Building a roadmap for developing combination therapies for Alzheimer’s disease

Steven Potkin, Michael Krams, Yaning Wang, 2015, Expert review of neurotherapeutics.

A response-adaptive design of initial therapy for emergency department patients with heart failure.

Jing Ning, Sean Collins, Sijin Wen, 2017, Contemporary clinical trials.

Pre-counseling education materials for BRCA testing: does tailoring make a difference?

Celette Sugg Skinner, Barbara K Rimer, Brian Calingaert, 2002, Genetic testing.

Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342

Donald Berry, Lyndsay N Harris, Lynn Dressler, 2006, Breast Cancer Research.

Charting a path toward combination therapy for Alzheimer’s disease

Michael Krams, Stephen Salloway, David Dilts, 2015, Expert review of neurotherapeutics.